APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infant Heel Safety Lancet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Infant Heel Safety Lancet Market Outlook and Growth Opportunities 2026

26 December 2025206 pages

Choose your research edition.

Industry ResearchInfant Heel Safety Lancet Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Infant Heel Safety Lancet Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Infant Heel Safety Lancet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infant Heel Safety Lancet Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Infant Heel Safety Lancet Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Infant Heel Safety Lancet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Infant Heel Safety Lancet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Infant Heel Safety Lancet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infant Heel Safety Lancet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Infant Heel Safety Lancet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Infant Heel Safety Lancet market include BD, Cardinal Health, Facet Medical Technologies, ICU Medical, I-Tech Healthcare, LABORIE, Laborie, MIN JIER FIRM and Natus Medical Incorporated, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Infant Heel Safety Lancet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Infant Heel Safety Lancet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Infant Heel Safety Lancet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Infant Heel Safety Lancet market size, projected growth trends, production technologies, key applications, and end-use industries.

Infant Heel Safety Lancet Segment by Company

BD

Cardinal Health

Facet Medical Technologies

ICU Medical

I-Tech Healthcare

LABORIE

Laborie

MIN JIER FIRM

Natus Medical Incorporated

Owen Mumford

SARSTEDT

SteriLance Medical

VWR International

Huahong

Ningbo Medsun Medical

Shandong Lianfa Medical Plastic Products

Infant Heel Safety Lancet Segment by Type

Plastic

Stainless Steel

Infant Heel Safety Lancet Segment by Application

Specialty Clinic

Hospital

Others

Infant Heel Safety Lancet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Infant Heel Safety Lancet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Infant Heel Safety Lancet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Infant Heel Safety Lancet significant trends, drivers, influence factors in global and regions.

6. To analyze Infant Heel Safety Lancet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infant Heel Safety Lancet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infant Heel Safety Lancet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infant Heel Safety Lancet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Infant Heel Safety Lancet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Infant Heel Safety Lancet industry.

Chapter 3: Detailed analysis of Infant Heel Safety Lancet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Infant Heel Safety Lancet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Infant Heel Safety Lancet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Infant Heel Safety Lancet Industry Trends Table 2. Infant Heel Safety Lancet Industry Drivers Table 3. Infant Heel Safety Lancet Industry Opportunities and Challenges Table 4. Infant Heel Safety Lancet Industry Restraints Table 5. Global Infant Heel Safety Lancet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Infant Heel Safety Lancet Revenue Share by Company (2021-2026) Table 7. Global Infant Heel Safety Lancet Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Infant Heel Safety Lancet Sales Volume Share by Company (2021-2026) Table 9. Global Infant Heel Safety Lancet Average Price (US$/K Unit) of Company (2021-2026) Table 10. Global Infant Heel Safety Lancet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Infant Heel Safety Lancet Key Company Manufacturing Base & Headquarters Table 12. Global Infant Heel Safety Lancet Company, Product Type & Application Table 13. Global Infant Heel Safety Lancet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Infant Heel Safety Lancet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plastic Table 18. Significant Companies of Stainless Steel Table 19. Global Infant Heel Safety Lancet Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Infant Heel Safety Lancet Sales Volume by Type (2021-2026) & (M Units) Table 21. Global Infant Heel Safety Lancet Sales Volume by Type (2027-2032) & (M Units) Table 22. Global Infant Heel Safety Lancet Sales Volume Share by Type (2021-2026) Table 23. Global Infant Heel Safety Lancet Sales Volume Share by Type (2027-2032) Table 24. Global Infant Heel Safety Lancet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Infant Heel Safety Lancet Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Infant Heel Safety Lancet Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Infant Heel Safety Lancet Sales Value Share by Type (2021-2026) Table 28. Global Infant Heel Safety Lancet Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Specialty Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Others Table 32. Global Infant Heel Safety Lancet Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Infant Heel Safety Lancet Sales Volume by Application (2021-2026) & (M Units) Table 34. Global Infant Heel Safety Lancet Sales Volume by Application (2027-2032) & (M Units) Table 35. Global Infant Heel Safety Lancet Sales Volume Share by Application (2021-2026) Table 36. Global Infant Heel Safety Lancet Sales Volume Share by Application (2027-2032) Table 37. Global Infant Heel Safety Lancet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Infant Heel Safety Lancet Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Infant Heel Safety Lancet Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Infant Heel Safety Lancet Sales Value Share by Application (2021-2026) Table 41. Global Infant Heel Safety Lancet Sales Value Share by Application (2027-2032) Table 42. Global Infant Heel Safety Lancet Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Infant Heel Safety Lancet Sales by Region (2021-2026) & (M Units) Table 44. Global Infant Heel Safety Lancet Sales Market Share by Region (2021-2026) Table 45. Global Infant Heel Safety Lancet Sales by Region (2027-2032) & (M Units) Table 46. Global Infant Heel Safety Lancet Sales Market Share by Region (2027-2032) Table 47. Global Infant Heel Safety Lancet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Infant Heel Safety Lancet Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Infant Heel Safety Lancet Sales Value Share by Region (2021-2026) Table 50. Global Infant Heel Safety Lancet Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Infant Heel Safety Lancet Sales Value Share by Region (2027-2032) Table 52. Global Infant Heel Safety Lancet Market Average Price (US$/K Unit) by Region (2021-2026) Table 53. Global Infant Heel Safety Lancet Market Average Price (US$/K Unit) by Region (2027-2032) Table 54. Global Infant Heel Safety Lancet Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Global Infant Heel Safety Lancet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Infant Heel Safety Lancet Sales by Country (2021-2026) & (M Units) Table 57. Global Infant Heel Safety Lancet Sales Market Share by Country (2021-2026) Table 58. Global Infant Heel Safety Lancet Sales by Country (2027-2032) & (M Units) Table 59. Global Infant Heel Safety Lancet Sales Market Share by Country (2027-2032) Table 60. Global Infant Heel Safety Lancet Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Infant Heel Safety Lancet Sales Value Market Share by Country (2021-2026) Table 62. Global Infant Heel Safety Lancet Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Infant Heel Safety Lancet Sales Value Market Share by Country (2027-2032) Table 64. BD Company Information Table 65. BD Business Overview Table 66. BD Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 67. BD Infant Heel Safety Lancet Product Portfolio Table 68. BD Recent Development Table 69. Cardinal Health Company Information Table 70. Cardinal Health Business Overview Table 71. Cardinal Health Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 72. Cardinal Health Infant Heel Safety Lancet Product Portfolio Table 73. Cardinal Health Recent Development Table 74. Facet Medical Technologies Company Information Table 75. Facet Medical Technologies Business Overview Table 76. Facet Medical Technologies Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 77. Facet Medical Technologies Infant Heel Safety Lancet Product Portfolio Table 78. Facet Medical Technologies Recent Development Table 79. ICU Medical Company Information Table 80. ICU Medical Business Overview Table 81. ICU Medical Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 82. ICU Medical Infant Heel Safety Lancet Product Portfolio Table 83. ICU Medical Recent Development Table 84. I-Tech Healthcare Company Information Table 85. I-Tech Healthcare Business Overview Table 86. I-Tech Healthcare Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 87. I-Tech Healthcare Infant Heel Safety Lancet Product Portfolio Table 88. I-Tech Healthcare Recent Development Table 89. LABORIE Company Information Table 90. LABORIE Business Overview Table 91. LABORIE Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 92. LABORIE Infant Heel Safety Lancet Product Portfolio Table 93. LABORIE Recent Development Table 94. Laborie Company Information Table 95. Laborie Business Overview Table 96. Laborie Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 97. Laborie Infant Heel Safety Lancet Product Portfolio Table 98. Laborie Recent Development Table 99. MIN JIER FIRM Company Information Table 100. MIN JIER FIRM Business Overview Table 101. MIN JIER FIRM Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 102. MIN JIER FIRM Infant Heel Safety Lancet Product Portfolio Table 103. MIN JIER FIRM Recent Development Table 104. Natus Medical Incorporated Company Information Table 105. Natus Medical Incorporated Business Overview Table 106. Natus Medical Incorporated Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 107. Natus Medical Incorporated Infant Heel Safety Lancet Product Portfolio Table 108. Natus Medical Incorporated Recent Development Table 109. Owen Mumford Company Information Table 110. Owen Mumford Business Overview Table 111. Owen Mumford Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 112. Owen Mumford Infant Heel Safety Lancet Product Portfolio Table 113. Owen Mumford Recent Development Table 114. SARSTEDT Company Information Table 115. SARSTEDT Business Overview Table 116. SARSTEDT Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 117. SARSTEDT Infant Heel Safety Lancet Product Portfolio Table 118. SARSTEDT Recent Development Table 119. SteriLance Medical Company Information Table 120. SteriLance Medical Business Overview Table 121. SteriLance Medical Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 122. SteriLance Medical Infant Heel Safety Lancet Product Portfolio Table 123. SteriLance Medical Recent Development Table 124. VWR International Company Information Table 125. VWR International Business Overview Table 126. VWR International Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 127. VWR International Infant Heel Safety Lancet Product Portfolio Table 128. VWR International Recent Development Table 129. Huahong Company Information Table 130. Huahong Business Overview Table 131. Huahong Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 132. Huahong Infant Heel Safety Lancet Product Portfolio Table 133. Huahong Recent Development Table 134. Ningbo Medsun Medical Company Information Table 135. Ningbo Medsun Medical Business Overview Table 136. Ningbo Medsun Medical Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 137. Ningbo Medsun Medical Infant Heel Safety Lancet Product Portfolio Table 138. Ningbo Medsun Medical Recent Development Table 139. Shandong Lianfa Medical Plastic Products Company Information Table 140. Shandong Lianfa Medical Plastic Products Business Overview Table 141. Shandong Lianfa Medical Plastic Products Infant Heel Safety Lancet Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 142. Shandong Lianfa Medical Plastic Products Infant Heel Safety Lancet Product Portfolio Table 143. Shandong Lianfa Medical Plastic Products Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Infant Heel Safety Lancet Distributors List Table 147. Infant Heel Safety Lancet Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Infant Heel Safety Lancet Product Image Figure 2. Global Infant Heel Safety Lancet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infant Heel Safety Lancet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Infant Heel Safety Lancet Sales (2021-2032) & (M Units) Figure 5. Global Infant Heel Safety Lancet Sales Average Price (US$/K Unit) & (2021-2032) Figure 6. Global Infant Heel Safety Lancet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plastic Image Figure 10. Stainless Steel Image Figure 11. Global Infant Heel Safety Lancet Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Infant Heel Safety Lancet Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Infant Heel Safety Lancet Sales Volume Share by Type (2021-2032) Figure 14. Global Infant Heel Safety Lancet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Infant Heel Safety Lancet Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Infant Heel Safety Lancet Sales Value Share by Type (2021-2032) Figure 17. Specialty Clinic Image Figure 18. Hospital Image Figure 19. Others Image Figure 20. Global Infant Heel Safety Lancet Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Infant Heel Safety Lancet Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Infant Heel Safety Lancet Sales Volume Share by Application (2021-2032) Figure 23. Global Infant Heel Safety Lancet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Infant Heel Safety Lancet Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Infant Heel Safety Lancet Sales Value Share by Application (2021-2032) Figure 26. Global Infant Heel Safety Lancet Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 27. Global Infant Heel Safety Lancet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Infant Heel Safety Lancet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Infant Heel Safety Lancet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Infant Heel Safety Lancet Sales Value (2021-2032) & (US$ Million) Figure 31. North America Infant Heel Safety Lancet Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Infant Heel Safety Lancet Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Infant Heel Safety Lancet Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Infant Heel Safety Lancet Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Infant Heel Safety Lancet Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Infant Heel Safety Lancet Sales Value (2021-2032) & (US$ Million) Figure 37. South America Infant Heel Safety Lancet Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Infant Heel Safety Lancet Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Infant Heel Safety Lancet Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Infant Heel Safety Lancet Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Infant Heel Safety Lancet Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Plastic
  • Stainless Steel
Applications
  • Specialty Clinic
  • Hospital
  • Others
Companies covered
  • BD
  • Cardinal Health
  • Facet Medical Technologies
  • ICU Medical
  • I-Tech Healthcare
  • LABORIE
  • Laborie
  • MIN JIER FIRM
  • Natus Medical Incorporated
  • Owen Mumford
  • SARSTEDT
  • SteriLance Medical
  • VWR International
  • Huahong
  • Ningbo Medsun Medical
  • Shandong Lianfa Medical Plastic Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Infant Heel Safety Lancet Sales Value (2021-2032)
  4. 1.2.2 Global Infant Heel Safety Lancet Sales Volume (2021-2032)
  5. 1.2.3 Global Infant Heel Safety Lancet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Infant Heel Safety Lancet Market Dynamics
  1. 2.1 Infant Heel Safety Lancet Industry Trends
  2. 2.2 Infant Heel Safety Lancet Industry Drivers
  3. 2.3 Infant Heel Safety Lancet Industry Opportunities and Challenges
  4. 2.4 Infant Heel Safety Lancet Industry Restraints
3 Infant Heel Safety Lancet Market by Company
  1. 3.1 Global Infant Heel Safety Lancet Company Revenue Ranking in 2025
  2. 3.2 Global Infant Heel Safety Lancet Revenue by Company (2021-2026)
  3. 3.3 Global Infant Heel Safety Lancet Sales Volume by Company (2021-2026)
  4. 3.4 Global Infant Heel Safety Lancet Average Price by Company (2021-2026)
  5. 3.5 Global Infant Heel Safety Lancet Company Ranking (2024-2026)
  6. 3.6 Global Infant Heel Safety Lancet Company Manufacturing Base and Headquarters
  7. 3.7 Global Infant Heel Safety Lancet Company Product Type and Application
  8. 3.8 Global Infant Heel Safety Lancet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Infant Heel Safety Lancet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Infant Heel Safety Lancet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Infant Heel Safety Lancet Market by Type
  1. 4.1 Infant Heel Safety Lancet Type Introduction
  2. 4.1.1 Plastic
  3. 4.1.2 Stainless Steel
  4. 4.2 Global Infant Heel Safety Lancet Sales Volume by Type
  5. 4.2.1 Global Infant Heel Safety Lancet Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Infant Heel Safety Lancet Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Infant Heel Safety Lancet Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Infant Heel Safety Lancet Sales Value by Type
  9. 4.3.1 Global Infant Heel Safety Lancet Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Infant Heel Safety Lancet Sales Value by Type (2021-2032)
  11. 4.3.3 Global Infant Heel Safety Lancet Sales Value Share by Type (2021-2032)
5 Infant Heel Safety Lancet Market by Application
  1. 5.1 Infant Heel Safety Lancet Application Introduction
  2. 5.1.1 Specialty Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Infant Heel Safety Lancet Sales Volume by Application
  6. 5.2.1 Global Infant Heel Safety Lancet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Infant Heel Safety Lancet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Infant Heel Safety Lancet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Infant Heel Safety Lancet Sales Value by Application
  10. 5.3.1 Global Infant Heel Safety Lancet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Infant Heel Safety Lancet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Infant Heel Safety Lancet Sales Value Share by Application (2021-2032)
6 Infant Heel Safety Lancet Regional Sales and Value Analysis
  1. 6.1 Global Infant Heel Safety Lancet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Infant Heel Safety Lancet Sales by Region (2021-2032)
  3. 6.2.1 Global Infant Heel Safety Lancet Sales by Region: 2021-2026
  4. 6.2.2 Global Infant Heel Safety Lancet Sales by Region (2027-2032)
  5. 6.3 Global Infant Heel Safety Lancet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Infant Heel Safety Lancet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Infant Heel Safety Lancet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Infant Heel Safety Lancet Sales Value by Region (2027-2032)
  9. 6.5 Global Infant Heel Safety Lancet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Infant Heel Safety Lancet Sales Value (2021-2032)
  12. 6.6.2 North America Infant Heel Safety Lancet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Infant Heel Safety Lancet Sales Value (2021-2032)
  15. 6.7.2 Europe Infant Heel Safety Lancet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Infant Heel Safety Lancet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Infant Heel Safety Lancet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Infant Heel Safety Lancet Sales Value (2021-2032)
  21. 6.9.2 South America Infant Heel Safety Lancet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Infant Heel Safety Lancet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Infant Heel Safety Lancet Sales Value Share by Country, 2025 VS 2032
7 Infant Heel Safety Lancet Country-level Sales and Value Analysis
  1. 7.1 Global Infant Heel Safety Lancet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Infant Heel Safety Lancet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Infant Heel Safety Lancet Sales by Country (2021-2032)
  4. 7.3.1 Global Infant Heel Safety Lancet Sales by Country (2021-2026)
  5. 7.3.2 Global Infant Heel Safety Lancet Sales by Country (2027-2032)
  6. 7.4 Global Infant Heel Safety Lancet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Infant Heel Safety Lancet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Infant Heel Safety Lancet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Infant Heel Safety Lancet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Infant Heel Safety Lancet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Infant Heel Safety Lancet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BD Infant Heel Safety Lancet Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 Cardinal Health
  8. 8.2.1 Cardinal Health Company Information
  9. 8.2.2 Cardinal Health Business Overview
  10. 8.2.3 Cardinal Health Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cardinal Health Infant Heel Safety Lancet Product Portfolio
  12. 8.2.5 Cardinal Health Recent Developments
  13. 8.3 Facet Medical Technologies
  14. 8.3.1 Facet Medical Technologies Company Information
  15. 8.3.2 Facet Medical Technologies Business Overview
  16. 8.3.3 Facet Medical Technologies Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Facet Medical Technologies Infant Heel Safety Lancet Product Portfolio
  18. 8.3.5 Facet Medical Technologies Recent Developments
  19. 8.4 ICU Medical
  20. 8.4.1 ICU Medical Company Information
  21. 8.4.2 ICU Medical Business Overview
  22. 8.4.3 ICU Medical Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ICU Medical Infant Heel Safety Lancet Product Portfolio
  24. 8.4.5 ICU Medical Recent Developments
  25. 8.5 I-Tech Healthcare
  26. 8.5.1 I-Tech Healthcare Company Information
  27. 8.5.2 I-Tech Healthcare Business Overview
  28. 8.5.3 I-Tech Healthcare Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 I-Tech Healthcare Infant Heel Safety Lancet Product Portfolio
  30. 8.5.5 I-Tech Healthcare Recent Developments
  31. 8.6 LABORIE
  32. 8.6.1 LABORIE Company Information
  33. 8.6.2 LABORIE Business Overview
  34. 8.6.3 LABORIE Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LABORIE Infant Heel Safety Lancet Product Portfolio
  36. 8.6.5 LABORIE Recent Developments
  37. 8.7 Laborie
  38. 8.7.1 Laborie Company Information
  39. 8.7.2 Laborie Business Overview
  40. 8.7.3 Laborie Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Laborie Infant Heel Safety Lancet Product Portfolio
  42. 8.7.5 Laborie Recent Developments
  43. 8.8 MIN JIER FIRM
  44. 8.8.1 MIN JIER FIRM Company Information
  45. 8.8.2 MIN JIER FIRM Business Overview
  46. 8.8.3 MIN JIER FIRM Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MIN JIER FIRM Infant Heel Safety Lancet Product Portfolio
  48. 8.8.5 MIN JIER FIRM Recent Developments
  49. 8.9 Natus Medical Incorporated
  50. 8.9.1 Natus Medical Incorporated Company Information
  51. 8.9.2 Natus Medical Incorporated Business Overview
  52. 8.9.3 Natus Medical Incorporated Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Natus Medical Incorporated Infant Heel Safety Lancet Product Portfolio
  54. 8.9.5 Natus Medical Incorporated Recent Developments
  55. 8.10 Owen Mumford
  56. 8.10.1 Owen Mumford Company Information
  57. 8.10.2 Owen Mumford Business Overview
  58. 8.10.3 Owen Mumford Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Owen Mumford Infant Heel Safety Lancet Product Portfolio
  60. 8.10.5 Owen Mumford Recent Developments
  61. 8.11 SARSTEDT
  62. 8.11.1 SARSTEDT Company Information
  63. 8.11.2 SARSTEDT Business Overview
  64. 8.11.3 SARSTEDT Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 SARSTEDT Infant Heel Safety Lancet Product Portfolio
  66. 8.11.5 SARSTEDT Recent Developments
  67. 8.12 SteriLance Medical
  68. 8.12.1 SteriLance Medical Company Information
  69. 8.12.2 SteriLance Medical Business Overview
  70. 8.12.3 SteriLance Medical Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 SteriLance Medical Infant Heel Safety Lancet Product Portfolio
  72. 8.12.5 SteriLance Medical Recent Developments
  73. 8.13 VWR International
  74. 8.13.1 VWR International Company Information
  75. 8.13.2 VWR International Business Overview
  76. 8.13.3 VWR International Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 VWR International Infant Heel Safety Lancet Product Portfolio
  78. 8.13.5 VWR International Recent Developments
  79. 8.14 Huahong
  80. 8.14.1 Huahong Company Information
  81. 8.14.2 Huahong Business Overview
  82. 8.14.3 Huahong Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Huahong Infant Heel Safety Lancet Product Portfolio
  84. 8.14.5 Huahong Recent Developments
  85. 8.15 Ningbo Medsun Medical
  86. 8.15.1 Ningbo Medsun Medical Company Information
  87. 8.15.2 Ningbo Medsun Medical Business Overview
  88. 8.15.3 Ningbo Medsun Medical Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Ningbo Medsun Medical Infant Heel Safety Lancet Product Portfolio
  90. 8.15.5 Ningbo Medsun Medical Recent Developments
  91. 8.16 Shandong Lianfa Medical Plastic Products
  92. 8.16.1 Shandong Lianfa Medical Plastic Products Company Information
  93. 8.16.2 Shandong Lianfa Medical Plastic Products Business Overview
  94. 8.16.3 Shandong Lianfa Medical Plastic Products Infant Heel Safety Lancet Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Shandong Lianfa Medical Plastic Products Infant Heel Safety Lancet Product Portfolio
  96. 8.16.5 Shandong Lianfa Medical Plastic Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Infant Heel Safety Lancet Value Chain Analysis
  2. 9.1.1 Infant Heel Safety Lancet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Infant Heel Safety Lancet Sales Mode & Process
  6. 9.2 Infant Heel Safety Lancet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Infant Heel Safety Lancet Distributors
  9. 9.2.3 Infant Heel Safety Lancet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst